Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ayahuasca vs Esketamine for Premenstrual Symptoms
NCT07317232Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ayahuasca in premenstrual syndrome (PMS) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Premenstrual Symptom Tracking Instrument at 3 weeks. Started Dec 2025; status: recruiting.
02
Drugs
ayahuasca
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on NCT07317232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07317232.